Streetbeat News

Stock Prices

LRCX

Lam Research (NASDAQ:LRCX) has significantly outperformed the market over the past 20 years, with an average annual return of 19.68%. A $100 investment in LRCX 20 years ago would now be worth $3,556.23. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 3:30 pm

AAPL

AMZN

ASHR

ECON

F

FXI

GM

GOOG

META

MSFT

NVDA

QQQ

SPY

STLA

TSLA

VWAGY

The Chinese stock market has experienced a significant rally, breaking a negative pattern with the CSI 300 index jumping 8.5%, the largest gain since 2008. This rally is driven by FOMO among foreign investors and a shift from Chinese Treasury bonds to stocks. Despite poor economic data, expectations are high for future growth due to government stimulus. The Arora Report has identified new buy zones for ETFs like ASHR, FXI, and ECON. Meanwhile, negative sentiment from Europe and poor guidance from automakers like Stellantis and Volkswagen are affecting US markets, with stocks like GM and Ford under pressure.

Portfolio Pulse from The Arora Report

September 30, 2024 | 3:27 pm

EIS

ISRA

SPY

USO

Israeli Defense Minister Gallant announced that the next phase of the war will begin soon. This development could impact various sectors, including defense and energy, and may influence related ETFs.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:24 pm

EIS

ISRA

SPY

USO

President Biden has called for a ceasefire, which may have implications for geopolitical stability and related markets.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:23 pm

ACB

CGC

CRON

GRWG

IGC

IMCC

OGI

SNDL

TLRY

Cannabis stocks are experiencing a surge in trading following a report that Vice President Harris is advocating for the legalization of marijuana.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:16 pm

SOBR

SOBRsafe shares are declining following the announcement of a 1-for-110 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:15 pm

ARM

ARM Holdings Inc. (NASDAQ:ARM) has seen a 2.31% decrease in its stock price to $142.22, despite a 14.93% increase over the past month and a 175.77% increase over the past year. The company's P/E ratio of 359.83 is significantly higher than the industry average of 58.88, raising questions about potential overvaluation.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 3:15 pm

ARCT

CSLLY

PFE

Arcturus Therapeutics and CSL Limited's COVID-19 vaccine, ARCT-154, demonstrated superior immunogenicity compared to Pfizer's Comirnaty in a Phase 3 study, even at lower doses. The vaccine showed better antibody responses against various COVID-19 variants, including Omicron, over a year. ARCT-2301, another vaccine from the same platform, also outperformed Comirnaty in inducing neutralizing antibodies.

Portfolio Pulse from Vandana Singh

September 30, 2024 | 3:12 pm

SOBR

SOBR Safe, Inc. (NASDAQ:SOBR) will implement a 1-for-110 reverse stock split on October 2, 2024, to increase its share price and comply with Nasdaq's listing requirements. The stock will trade under the same symbol 'SOBR' with a new CUSIP number.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:09 pm